[go: up one dir, main page]

NO20054762L - Polymorphs of aripiprazole - Google Patents

Polymorphs of aripiprazole

Info

Publication number
NO20054762L
NO20054762L NO20054762A NO20054762A NO20054762L NO 20054762 L NO20054762 L NO 20054762L NO 20054762 A NO20054762 A NO 20054762A NO 20054762 A NO20054762 A NO 20054762A NO 20054762 L NO20054762 L NO 20054762L
Authority
NO
Norway
Prior art keywords
aripiprazole
polymorphs
compounds
preparation
disclosed
Prior art date
Application number
NO20054762A
Other languages
English (en)
Other versions
NO20054762D0 (no
Inventor
Braj Bhushan Lohray
Vidya Bhushan Lohray
Kaushik Sata
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Publication of NO20054762D0 publication Critical patent/NO20054762D0/no
Publication of NO20054762L publication Critical patent/NO20054762L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Det beskrives nye polymorfer av aripiprazol, deres fremstilling, samt farmasøytiske preparater inneholdende forbindelsene og deres anvendelse.
NO20054762A 2003-04-25 2005-10-17 Polymorphs of aripiprazole NO20054762L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN412MU2003 2003-04-25
IN583MU2003 2003-06-06
PCT/IN2004/000113 WO2004106322A2 (en) 2003-04-25 2004-04-22 Polymorphs of aripiprazole

Publications (2)

Publication Number Publication Date
NO20054762D0 NO20054762D0 (no) 2005-10-17
NO20054762L true NO20054762L (no) 2006-01-24

Family

ID=33492303

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054762A NO20054762L (no) 2003-04-25 2005-10-17 Polymorphs of aripiprazole

Country Status (4)

Country Link
US (1) US20060270683A1 (no)
EP (1) EP1618103A2 (no)
NO (1) NO20054762L (no)
WO (1) WO2004106322A2 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5546717B2 (ja) * 2003-12-16 2014-07-09 テバ ファーマシューティカル インダストリーズ リミティド アリピプラゾール結晶質形態を調製する方法
US7714129B2 (en) 2003-12-16 2010-05-11 Teva Pharmaceutical Industries Ltd. Methods of preparing anhydrous aripiprazole form II
CN1914175A (zh) 2004-02-05 2007-02-14 特瓦制药工业有限公司 7-(4-溴丁氧基)-3,4-二氢喹诺酮的制备方法
US7507823B2 (en) 2004-05-06 2009-03-24 Bristol-Myers Squibb Company Process of making aripiprazole particles
EP1812397A1 (en) * 2004-11-18 2007-08-01 Synthon B.V. Process of making crystalline aripiprazole
WO2006079549A1 (en) 2005-01-27 2006-08-03 Sandoz Ag Salts of aripiprazole
EP1686126A1 (en) * 2005-01-27 2006-08-02 Sandoz AG Salts of aripiprazole
CA2600541C (en) * 2005-03-17 2018-01-09 Synthon B.V. Process of making crystalline type ii aripiprazole
WO2006097344A1 (en) * 2005-03-17 2006-09-21 Synthon B.V. Pharmaceutical tablets of crystalline type ii aripiprazole
US20090247542A1 (en) * 2005-04-15 2009-10-01 Medichem, S.A. Syntheses and preparations of polymorphs of crystalline aripiprazole
HUP0500683A3 (en) * 2005-07-14 2009-03-30 Egis Gyogyszergyar Nyilvanosan New arylpiprazole salts for producing pharmaceutical composition
TW200800202A (en) * 2005-12-22 2008-01-01 Teva Pharma Processes for reducing particle size of aripiprazole
WO2007081367A1 (en) * 2006-01-05 2007-07-19 Teva Pharmaceutical Industries Ltd. Dry formulations of aripiprazole
EP1808164B2 (en) * 2006-01-05 2018-07-04 Teva Pharmaceutical Industries Ltd Wet granulation method for preparing pharmaceutical compositions of aripiprazole
EP1880714A1 (en) 2006-07-20 2008-01-23 Helm AG Amorphous Aripiprazole and Process for the Preparation thereof
US7799790B2 (en) 2006-07-20 2010-09-21 Helm Ag Amorphous aripiprazole and process for the preparation thereof
WO2008020453A2 (en) * 2006-08-17 2008-02-21 Unichem Laboratories Limited A process for the preparation of a novel crystalline polymorph of aripiprazole
ES2353444T3 (es) 2008-01-23 2011-03-02 Helm Ag Aripiprazol amorfo y procedimiento para su preparación.
EP2238976B1 (en) 2009-04-03 2012-06-27 Hexal AG Oral films comprising 7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro- 1H-quinolin-2-one base or salts or hydrates thereof
US9156822B2 (en) 2010-07-02 2015-10-13 The University Of North Carolina At Chapel Hill Functionally selective ligands of dopamine D2 receptors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006528A (en) * 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
AR033485A1 (es) * 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma

Also Published As

Publication number Publication date
WO2004106322A2 (en) 2004-12-09
US20060270683A1 (en) 2006-11-30
EP1618103A2 (en) 2006-01-25
NO20054762D0 (no) 2005-10-17
WO2004106322A3 (en) 2005-04-21

Similar Documents

Publication Publication Date Title
NO20054762L (no) Polymorphs of aripiprazole
SE0301372D0 (sv) Novel compounds
NO20093060L (no) Spirosykliske sykloheksanderivater
IL175512A0 (en) Methods of preparing aripiprazole crystalline forms
SE0101675D0 (sv) Novel composition
SE0301700D0 (sv) Novel compounds
NO20091299L (no) Substituerte sulfonamidderivater
NO2014009I2 (no) Forbindelser, farmasøytiske sammensetninger og anvendelser derav, samt fremgangsmåte for å fremstille nevnte forbindelser
NO20054032D0 (no) Glykolipidderivater, fremgangsmate for fremstilling derav, mellomprodukter for fremstilling derav oq fremgangsmater for fremstilling av mellomproduktene.
SE0302811D0 (sv) Novel compounds
NO20085373L (no) P38 inhibitorer, deres fremstilling og anvendelse
NO20052493D0 (no) Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og deres anvendelse som farmasoytiske sammensetninger.
NO20054083L (no) Nye sammenkoblede triazoloner og deres anvendelse
NO20044261L (no) Indazoler substituerte med en anticanceros aktivitet
WO2004089947A3 (de) Neue verbindungen mit antibakterieller aktivität
SE0301653D0 (sv) Novel compounds
HUS1500006I1 (hu) Benzotiazol-származék vegyületek, kompozíciók és alkalmazások
WO2004093800A3 (en) Thyronamine derivatives and analogs and methods of use thereof
GB0308201D0 (en) Novel compounds
WO2006009765A3 (en) Methods for the identification and use of compounds suitable for the treatment of drug resistant cancer cells
SE0302546D0 (sv) New compounds
NO20070564L (no) Kinoliner uten tiazolinonsubstituenter.
EA200702589A1 (ru) 2,6-хинолинильные производные, способы их получения и их применение
BRPI0515721A (pt) uso de um inibidor de src cinase e um inibidor de bcr-abl, composição farmacêutica e combinação
NO20050019L (no) Polytylenglykolaldehyd-derivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application